Filter
569
Text search:
oxygen
sources
Featured
Recommendations
93
New Publications
97
Language
Document type
No document type
222
Studies & Reports
113
Guidelines
113
Manuals
55
Strategic & Response Plan
33
Training Material
17
Fact sheets
12
Infographics
2
Brochures
1
Situation Updates
1
Countries / Regions
India
31
Global
25
Kenya
18
Rwanda
17
Ethiopia
15
Nigeria
13
Ghana
12
South Africa
12
Bangladesh
12
Uganda
11
Syria
9
Myanmar / Burma
9
Liberia
8
Tanzania
8
Western and Central Europe
8
Malawi
7
Ukraine
7
Africa
7
Philippines
6
Zambia
6
South–East Asia Region
6
Sierra Leone
5
Namibia
5
Latin America and the Carribbean
5
Senegal
4
USA
4
Nepal
4
South Sudan
4
Brazil
4
Congo, Democratic Republic of
3
Haiti
3
Eswatini/ Swaziland
3
East and Southern Africa
3
West and Central Africa
3
Eastern Europe and Central Asia
3
Guinea
2
Burkina Faso
2
Mali
2
Côte d’Ivoire / Ivory Coast
2
Pakistan
2
Iraq
2
Indonesia
2
Russia
2
Moldova
2
Cameroon
1
Zimbabwe
1
Germany
1
China
1
Mozambique
1
Sudan
1
Benin
1
North Macedonia
1
Ecuador
1
Botswana
1
Guatemala
1
Yemen
1
Middle East and North Africa
1
Other region
1
Asia
1
Eastern Europe
1
Congo-Brazzaville
1
Timor Leste/ East Timor
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
224
Key Resources
53
Clinical Guidelines
47
Women & Child Health
39
Public Health
29
Pharmacy & Technologies
8
Capacity Building
6
Toolboxes
COVID-19
127
Planetary Health
43
Caregiver
33
Conflict
18
Pharmacy
17
Rapid Response
15
NCDs
15
Specific Hazards
14
Global Health Education
13
Ebola & Marburg
12
Mental Health
12
TB
12
NTDs
11
AMR
9
2.0 Rapid Response
8
Disability
7
Natural Hazards
7
Health Financing Toolbox
6
Refugee
5
HIV
4
Malaria
2
Cholera
1
Polio
1
Zika
1
Social Ethics
1
This guide to local production of WHO-recommended handrub formulations is separated into two discrete but interrelated sections:
Part A provides a practical guide for use at the pharmacy bench during the actual preparation of the formulation. Users may want to display the material on the wall of
...
This document updates the earlier version published in April 2020. In recent weeks, information on the potential use of chloroquine or hydroxychloroquine for the treatment of people with COVID-19 has been disseminated in academic journals and public media. Although there are now ongoing clinical tri
...
he National Institute of statistics of Rwanda (NISR) in collaboration with the worldwide Demographic and Health Surveys Program implemented the 2014-15 Rwanda Demographic and Health Survey (RDHS) to collect data for monitoring progress on health programs and policies in Rwanda. This publication illu
...
The Infection Prevention and Control (IPC) Guidelines aim to support healthcare workers improve quality and safety health care. The Guidelines further aim to promote and facilitate the overall goal of IPC by providing evidence-based recommendations on the critical aspects of IPC, focusing on the fun
...
Community Assessment For Public Health Emergency Response (Casper) Toolkit; third edition 3.2
recommended
2nd edition
The Compendium brings together for the first time key consensus-based policy recommendations and guidance to improve the delivery of proven interventions to women and children. The user-friendly format incorporates icons and tabs to present key health-related policies that support the delivery of es
...
Over the 20 years that followed, this unique partnership has invested more than US$53 billion, saving 44 million lives and reducing the combined death rate from the three diseases by more than half in the countries in which the Global Fund invests.
16-24 February 2020
Community Health Volunteers
Concentrations of the major greenhouse gases, CO2 , CH4 , and N2 O, continued to increase despite the temporary reduction in emissions in 2020 related to measures taken in response to COVID-19.
2020 was one of the three warmest years on record. The past six years, including 2020, have been the si
...
Tuberculosis (TB) is, and should be, a curable disease; however, each year significant numbers of patients acquire or develop drug-resistant TB, which has a much lower cure rate. Patients with drug-resistant TB have a high prevalence of symptoms; hence, staff caring for these patients should h
...